Insufficient endogenous control of tumor necrosis factor-α contributes to temporomandibular joint pain and tissue destruction in rheumatoid arthritis

Journal of Rheumatology

Volumn 33, Issue 9, 2006, Pages 1734-1739

  Alstergren, Per ^a   Kopp, Sigvard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Arthritis; Cytokine receptors; Rheumatoid arthritis; Temporomandibular joint; Tumor necrosis factor

Indexed keywords

AURANOFIN; C REACTIVE PROTEIN; CYTOKINE RECEPTOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ANTIBODY DETECTION; ARTHRALGIA; ARTHRITIS; ARTICLE; BITE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; JAW MOVEMENT; MAJOR CLINICAL STUDY; MALE; MANDIBLE; PAIN ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER; THROMBOCYTE COUNT;

ARTHRALGIA; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; STATISTICS; STATISTICS AS TOPIC; TEMPOROMANDIBULAR JOINT DISORDERS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748570156     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Scott DL. Prognostic factors in early rheumatoid arthritis. Rheumatol 2000;39 Suppl 1:24-9.
2. Brennan FM, Maini RN, Feldmann M. Role of pro-inflammatory cytokines in rheumatoid arthritis. Springer Semin Immunopathol 1998;20:133-47.
3. Beyaert R, Fiers W. Tumor necrosis factor and lymphotoxin. In: Mire-Sluis AR, Thorpe R, editors. Cytokines. London: Academic Press; 1988:335-60.
4. Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF. Characterization of cytokine-induced hyperalgesia. Brain Res 1994;654:15-26.
5. van de Loo FA, Joosten LA, van Lent PL, Arntz OJ, van den Berg WB. Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995;38:164-72.
6. Nordahl S, Alstergren P, Kopp S. Tumor necrosis factor-alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain. J Oral Maxillofac Surg 2000;58:525-30.
7. Duff GW. Cytokines and acute phase proteins in rheumatoid arthritis. Scand J Rheumatol 1994;100 Suppl:9-19.
8. Voog U, Alstergren P, Eliasson S, Leibur E, Kallikorm R, Kopp S. Inflammatory mediators and radiographic changes in temporomandibular joints of patients with rheumatoid arthritis. Acta Odontol Scand 2003;61:57-64.
9. Olsson I. The cytokine network. J Intern Med 1993;233:103-5.
10. Jouvenne P, Vannier E, Dinarello CA, Miossec P. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction. Arthritis Rheum 1998;41:1083-9.
11. Arend WP. IL-1 antagonism in inflammatory arthritis. Lancet 1993;341:155-6.
12. Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998;16:457-99.
13. Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000;343:1594-602.
14. Charles P, Elliott MJ, Davis D, et al. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol 1999;163:1521-8.
15. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Okeson JP. Differential diagnosis and management considerations in temporomandibular disorders. In: Okeson JP. Orofacial pain - Guidelines for assessment, diagnosis and management. Carol Stream, IL: Quintessence; 1996:113-84.
17. Kopp S, Alstergren P, Ernestam S, Nordahl S, Morin P, Bratt J. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis. Cells Tissues Organs 2005;180:22-30.
18. Alstergren P, Benavente C, Kopp S. Interleukin-1beta, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides. J Oral Maxillofac Surg 2003 Oct;61:1171-8.
19. Voog U, Alstergren P, Leibur E, Kallikorm R, Kopp S. Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis. Mediators Inflamm 2004;13:373-6.
20. Fredriksson L, Alstergren P, Kopp S. Serotonergic mechanisms influence the response to glucocorticoid treatment in TMJ arthritis. Mediators Inflamm 2005;4:194-201.
21. Aderka D, Engelmann H, Wysenbeek AJ, Levo Y. The possible role of tumor necrosis factor (TNF) and its natural inhibitors, the soluble-TNF receptors, in autoimmune diseases. Isr J Med Sci 1992;28:126-30.
22. Nordahl S, Alstergren P, Eliasson S, Kopp S. Interleukin-1beta in plasma and synovial fluid in relation to radiographic changes in arthritic temporomandibular joints. Eur J Oral Sci 1998;106:559-63.
23. Mulherin D, Fitzgerald O, Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 1996;35:1263-8.
24. Kirwan JR. Conceptual issues in scoring radiographic progression in rheumatoid arthritis. J Rheumatol 1999;26:720-5.
25. Robak T, Gladalska A, Stepien H. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis. Eur Cytokine Netw 1998;9:145-54.
26. Roux-Lombard P, Punzi L, Hasler F, et al. Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 1993;36:485-9.